Lacrimal occlusion therapy for the treatment of superior limbic keratoconjunctivitis

Optometry and Vision Science

Volumn 75, Issue 10, 1998, Pages 714-718

  Rabat, Alan G ^a,b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Lacrimal occlusion; Lodoxamide tromethamine; Mucus filaments; Silicone lacrimal implant; Superior limbic keratoconjunctivitis; Thyroid disease

Indexed keywords

BIOCOMPATIBILITY; IMMUNOLOGY; IMPLANTS (SURGICAL); PATIENT TREATMENT; SILICONES;

IODOXAMIDE TROMETHAMINE; LACRIMAL OCCLUSION THERAPY; MUCUS FILAMENTS; SILICONE LACRIMAL IMPLANTS; SUPERIOR LIMBIC KERATOCONJUNCTIVITIS; THYROID DISEASE;

OPHTHALMOLOGY;

AKWA TEARS; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; COLLAGEN IMPLANT; LODOXAMIDE TROMETAMOL; LUBRICATING AGENT; OFLOXACIN; RETINOL; RIMEXOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CAUTERIZATION; FEMALE; HUMAN; KERATOCONJUNCTIVITIS; LACRIMAL DUCT OCCLUSION; PRIORITY JOURNAL; SYMPTOMATOLOGY; TOPICAL DRUG ADMINISTRATION;

EID: 0032191521     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006324-199810000-00015     Document Type: Article

References (19)

1. Theodore FH. Superior limbic keratoconjunctivitis. Eye Ear Nose Throat Mon 1963;42:25-8.
2. Thygeson P, Kimura SJ. Chronic conjunctivitis. Trans Am Acad Ophthalmol Otolaryngol 1963;67:494-517.
3. Corwin ME. Superior limbic keratoconjunctivitis. Am J Ophthalmol 1968;66:338-40.
4. Theodore FH. Further observations on superior limbic keratoconjunctivitis. Trans Am Acad Ophthalmol Otolaryngol 1967;71:341-51.
5. Cher I. Clinical features of superior limbic keroconjunctivitis in Aus-tralia. A probable association with thyrotoxicosis. Arch Ophthalmol 1969;82:580-6.
6. Kadrmas EF, Bartley GB. Superior limbic keratoconjunctivitis. A prognostic sign for severe Graves ophthalmopathy. Ophthalmology (Rochester) 1995;102:1472-5.
7. Yang HY, Fujishima H, Toda I, Shimazaki J, Tsubota K. Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol 1997;124:80-7.
8. Wilson FM, Ostler HB. Superior limbic keratoconjunctivitis. Int Ophthalmol Clin 1986;26:99-112.
9. Theodore FH, Ferry AP. Superior limbic keratoconjunctivitis. Clinical and pathological correlations. Arch Ophthalmol 1970;84:481-4.
10. Wright P. Superior limbic keratoconjunctivitis. Trans Ophthalmol Soc UK 1972;92:555-60.
11. Passons GA, Wood TO. Conjunctival resection for superior limbic keratoconjunctivitis. Ophthalmology (Rochester) 1984;91:966-8.
12. Udell IJ, Kenyon KR, Sawa M, Dohlman CH. Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva. Ophthalmology (Rochester) 1986;93:162-6.
13. Ohashi Y, Watanabe H, Kinoshita S, Hosotani H, Umemoto M, Manabe R. Vitamin A eyedrops for superior limbic keratoconjunctivitis. Am J Ophthalmol 1988;105:523-7.
14. Mondino BJ, Zaidman GW, Salamon SW. Use of pressure patching and soft contact lenses in superior limbic keratoconjunctivitis. Arch Ophthalmol 1982;100:1932-4.
15. Tenzel RR. Resistant superior limbic keratoconjunctivitis. Arch Ophthalmol 1973;89:439.
16. Donshik PC, Collin HB, Foster CS, Cavanagh HD, Boruchoff SA. Conjunctival resection treatment and ultrastructural histopathology of superior limbic keratoconjunctivitis. Am J Ophthalmol 1978;85:101-10.
17. Confino J, Brown SI. Treatment of superior limbic keratoconjunctivitis with topical cromolyn sodium. Ann Ophthalmol 1987;19:129-31.
18. Grutzmacher RD, Foster RS, Feiler LS. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis. Am J Ophthalmol 1995;120:400-2.
19. Dixon M, Jackson DM, Richards IM. The action of sodium cromoglycate on "C" fibre endings in the dog lung. Br J Pharmacol 1980;70:11-3.